Latest Breaking News On - Cancer research network - Page 2 : comparemela.com

Low-risk DCIS patients may safely skip radiotherapy after surgery, study finds

Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received adjuvant radiotherapy, according to results from the E4112 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

San antonioUnited statesSeemaa khanFeinberg school of medicineBluhm family professor of cancer researchCancer research groupLurie comprehensive cancer centerCancer research networkAlliance for clinical trials in oncologyNorthwestern universityAmerican association for cancer researchSan antonio breast cancer symposiumBluhm family professorCancer researchFeinberg schoolResearch group

Combo Treatment Sans Chemotherapy Effective for Ph+ ALL Elderly

Combo Treatment Sans Chemotherapy Effective for Ph+ ALL Elderly
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesMark litzowMatthew wieduwiltCeciliacs yeungEhabl atallahAnna moseleySusanm obrienAaront gerdsMegan othusJanel liesveldBrentl woodHarryp erbaAnjalis advaniKristen odwyerElad sharonJeraldp radich

Skipping adjuvant radiotherapy may not impact risk of recurrence or progression in patients with low-risk DCIS

Skipping adjuvant radiotherapy may not impact risk of recurrence or progression in patients with low-risk DCIS
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesSeemaa khanFeinberg school of medicineBluhm family professor of cancer researchNorthwestern universityLurie comprehensive cancer centerCancer research networkCancer research groupAlliance for clinical trials in oncologySan antonio breast cancer symposiumBluhm family professorCancer researchFeinberg schoolClinical trials

Model Predicts Risk of Non-Adherence to Aromatase Inhibitor

Model Predicts Risk of Non-Adherence to Aromatase Inhibitor
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesSan antonioJulier gralowJoseph ungerKathrynb arnoldN lynn henryAlfredi neugutScottd ramseyAnna moseleyCancer research networkNational cancer institute clinical trials networkCommunity oncology research programColumbia university irving medical centerUniversity of michigan rogel cancer centerColumbia universityBreast cancer research foundation

Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk

Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesSan antonioJoseph ungerColumbia university irving medical centerCancer research networkHerbert irving comprehensive cancer centerAmerican cancer society professor of medicineFred hutchinson cancer centerAntonio breast cancer symposiumAmerican cancer society professorClinical oncologyRisk factorsAromatase inhibitor non adherenceBreast cancer enrolledAntonio breast cancer